Precision BioSciences, Inc.
DTIL
$4.62
-$0.13-2.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -339.46% | -8.94% | -103.30% | 375.41% | 134.27% |
| Total Depreciation and Amortization | -50.60% | -51.35% | -50.34% | -42.05% | -37.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 124.26% | -177.38% | 90.92% | -188.37% | -236.96% |
| Change in Net Operating Assets | 93.63% | -69.51% | 178.08% | -165.43% | -35.44% |
| Cash from Operations | -0.37% | -121.81% | 74.40% | 29.64% | 39.67% |
| Capital Expenditure | 25.58% | -473.08% | 89.90% | 97.40% | 83.49% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 50.00% | -- | -- |
| Cash from Investing | -1,107.69% | -330.95% | -100.85% | 97.35% | 96.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -73.35% | 110.04% | -- | -62.10% | 5,310.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -73.35% | 109.34% | 11,079.41% | -62.10% | 5,310.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -141.16% | -131.59% | 85.59% | 30.20% | 167.07% |